Linezolid, Alosetron, Levetiracetam.
D000081:Acetamides / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D000328:Adult; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D000927:Anticonvulsants / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D002243:Carbolines / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use; D003109:Colonic Diseases, Functional / Q000188:drug therapy; D000075202:Contraindications; D004347:Drug Interactions; D005260:Female; D006801:Humans; D000077287:Levetiracetam; D000069349:Linezolid; D023303:Oxazolidinones / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use; D010889:Piracetam / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D012702:Serotonin Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics
D000081:Acetamides; D000890:Anti-Infective Agents; D000927:Anticonvulsants; D002243:Carbolines; D023303:Oxazolidinones; D012702:Serotonin Antagonists; C090840:alosetron; D000077287:Levetiracetam; D000069349:Linezolid; D010889:Piracetam